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Identity 
Hugo: PPM1D 
Other names: Wip1 phosphatase; PP2C delta 
(PP2Cd); EC 3.1.3.16 
Location: 17q23 
Local order: Centromere - USP32- APPBP2 - PPM1D 
- BCAS3 - telomere. 
DNA/RNA 
Description 
The gene encompasses 64.5 kb of DNA; 6 exons; 
several SNPs have been found. 
Transcription 
Transcript length: 3,163 bps. Several splice forms have 
been predicted. 
Wip1 mRNA transcription is induced in a p53-
dependent manner after stress, however p53-
independent induction of Wip1 mRNA also has been 
described. For example, E2F1 was shown to regulate 
Wip1 expression as well. 
Protein 
Note: Other names: Protein phosphatase 2C isoform 
delta (EC 3.1.3.16) (PP2C-delta) (p53- induced protein 
phosphatase 1) (Protein phosphatase magnesium- 
dependent 1 delta). 
Description 
605 amino acids; predicted size almost 65 kDa, 
however overexpressed Wip1 runs at almost 83 kDa. 
Expression 
Widely expressed (human expression). 
Localisation 
Primarily nucleus. 
Function 
Wip1 phosphatase is a weak oncogene that can 
compliment other oncogenes (Hras, Neu) in 
transformation of primary rodent cells with low 
efficiency. Does not complement p53-deficient cells. 
Wip1 phophatase has broad substrate specificity 
towards the threonine (p38 and UNG) or the serine 
residues (ATM, Chk2, p53, H2AX). Deficiency of 
Wip1 results in activation of p38- and ATM/Chk2-
dependent signaling pathways. Inactivation of Wip1 
suppresses the ability of mouse embryo fibroblasts 
undergo transformation in vitro and grow into tumors 
when explanted into nude mice. Wip1-deficient mice 
are resistant to multiple types of cancer including breast 
cancer and B-cell lymphomas. 
Homology 
Other PP2C phosphatases. 
Mutations 
Note: Have not been described. 
Implicated in 
Primary breast cancer 
Disease 
Wip1 overexpression primarily due to its gene 
amplification was found in almost 15% of primary 
breast cancers. Majority of Wip1-overexpressing 
tumors also have structurally intact p53. 
Overexpression of Wip1 inversely correlates with the 
level of active (phospho-) p38 MAPK. Wip1-
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overexpressing tumors also exhibited no or low levels 
of p16, which normally accumulates upon p38 MAPK 
activation. PPM1D amplification is associated with 
ERBB2 expression implying that PPM1D 
overexpression occurs in tumors with poor prognosis. 
Prognosis 
High expression correlates with poor prognosis. 
Neuroblastoma 
Prognosis 
High expression correlates with poor clinical outcome. 
Pancreatic adenocarcinoma 
Prognosis 
High expression correlates with poor prognosis. 
Ovarian adenocarcinomas 
Prognosis 
High expression correlates with poor prognosis. 
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